The 17th International Congress on APS took place in Cordoba, Argentina, on May 12-15, 2022.
During the ICAPA program many exciting and evolving topics have been reviewed , discussed and debated, all of great relevance across a range of medical subspecialties including Rheumatology, Internal Medicine, Haematology, Obstetrics, Cardiology and Neurology. The scientific aspects of the congress spanned to many disciplines including Genetics, Vascular Biology, Immunology, Diagnostics and Thrombosis & Haemostasis.
Similarly to former editions, the format of the congress was divided into 5 main sessions:
- Evidence-based, state-of-the art presentations from internationally recognized physicians and scientists
- Task Force discussions and presentations covering the controversial aspects of diagnosis and management
- Oral and poster submitted abstract presentations
- Meet the professor sessions
- Patient sessions guided by leaders in the field
This edition of the ICAPA was “Hybrid” with a total of 1513 registered attendees: 521 on site, 535 virtual and 457 patients.
On Friday 13th of May our Werfen satellite symposium was held with the participation of renowned speakers in the field of APS.
The first lecture from Prof. Savino Sciascia focused on the value of aPS/PT as an added value in the diagnosis and prognosis of APS. Dr. Maria Laura Bertolaccini then showed the value of including the aPS/PT test in routing and finally Dr. Carlos Ramirez dwelled on the newly generated APS data using our novel Aptiva platform.
As one of the main ICAPA sponsor, we arranged a booth for the participants on site (focusing on the BIO-FLASH and the full APS panel) and an e-booth for the virtual participants (displaying the full Werfen autoimmunity portfolio, including our novel PMAT technology)
We thank all the participants